Index by author
Jensen, J.H.
- Pediatric NeuroimagingYou have accessDiffusional Kurtosis Imaging of the Developing BrainA. Paydar, E. Fieremans, J.I. Nwankwo, M. Lazar, H.D. Sheth, V. Adisetiyo, J.A. Helpern, J.H. Jensen and S.S. MillaAmerican Journal of Neuroradiology April 2014, 35 (4) 808-814; DOI: https://doi.org/10.3174/ajnr.A3764
Jin, J.N.
- FELLOWS' JOURNAL CLUBNeurointerventionOpen AccessStent-Assisted Coiling versus Coiling Alone in Unruptured Intracranial Aneurysms in the Matrix and Platinum Science Trial: Safety, Efficacy, and Mid-Term OutcomesS.W. Hetts, A. Turk, J.D. English, C.F. Dowd, J. Mocco, C. Prestigiacomo, G. Nesbit, S.G. Ge, J.N. Jin, K. Carroll, Y. Murayama, A. Gholkar, S. Barnwell, D. Lopes, S.C. Johnston and C. McDougall on behalf of the Matrix and Platinum Science Trial InvestigatorsAmerican Journal of Neuroradiology April 2014, 35 (4) 698-705; DOI: https://doi.org/10.3174/ajnr.A3755
These authors analyzed data on 131 non-selected MCA aneurysms treated during a 6-year period. One month after treatment, permanent morbidity and mortality was 3.3% without significant differences according to technique used. The rate of recanalization was nearly 16%, also without differences according to technique, and re-treatment was needed in 7.6% of cases. A greater rate of complications occurred with balloon remodeling and only large aneurysm size predicted recanalization. The authors concluded that endovascular treatment of MCA aneurysms is safe, effective, and durable.
Johnston, S.C.
- FELLOWS' JOURNAL CLUBNeurointerventionOpen AccessStent-Assisted Coiling versus Coiling Alone in Unruptured Intracranial Aneurysms in the Matrix and Platinum Science Trial: Safety, Efficacy, and Mid-Term OutcomesS.W. Hetts, A. Turk, J.D. English, C.F. Dowd, J. Mocco, C. Prestigiacomo, G. Nesbit, S.G. Ge, J.N. Jin, K. Carroll, Y. Murayama, A. Gholkar, S. Barnwell, D. Lopes, S.C. Johnston and C. McDougall on behalf of the Matrix and Platinum Science Trial InvestigatorsAmerican Journal of Neuroradiology April 2014, 35 (4) 698-705; DOI: https://doi.org/10.3174/ajnr.A3755
These authors analyzed data on 131 non-selected MCA aneurysms treated during a 6-year period. One month after treatment, permanent morbidity and mortality was 3.3% without significant differences according to technique used. The rate of recanalization was nearly 16%, also without differences according to technique, and re-treatment was needed in 7.6% of cases. A greater rate of complications occurred with balloon remodeling and only large aneurysm size predicted recanalization. The authors concluded that endovascular treatment of MCA aneurysms is safe, effective, and durable.